Newgenivf Group Limited Stock Total Debt
| NIVF Stock | 0.39 0.02 4.88% |
NewGenIvf Group Limited fundamentals help investors to digest information that contributes to NewGenIvf Group's financial success or failures. It also enables traders to predict the movement of NewGenIvf Stock. The fundamental analysis module provides a way to measure NewGenIvf Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NewGenIvf Group stock.
The current Total Debt To Capitalization is estimated to decrease to -1.84. NewGenIvf |
NewGenIvf Group Limited Company Total Debt Analysis
NewGenIvf Group's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current NewGenIvf Group Total Debt | 1.62 M |
Most of NewGenIvf Group's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NewGenIvf Group Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
NewGenIvf Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for NewGenIvf Group is extremely important. It helps to project a fair market value of NewGenIvf Stock properly, considering its historical fundamentals such as Total Debt. Since NewGenIvf Group's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of NewGenIvf Group's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of NewGenIvf Group's interrelated accounts and indicators.
Click cells to compare fundamentals
NewGenIvf Total Debt Historical Pattern
Today, most investors in NewGenIvf Group Stock are looking for potential investment opportunities by analyzing not only static indicators but also various NewGenIvf Group's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of NewGenIvf Group total debt as a starting point in their analysis.
NewGenIvf Group Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
NewGenIvf Short Long Term Debt Total
Short Long Term Debt Total |
|
Based on the latest financial disclosure, NewGenIvf Group Limited has a Total Debt of 1.62 M. This is 99.94% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The total debt for all United States stocks is 99.97% higher than that of the company.
NewGenIvf Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NewGenIvf Group's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NewGenIvf Group could also be used in its relative valuation, which is a method of valuing NewGenIvf Group by comparing valuation metrics of similar companies.NewGenIvf Group is currently under evaluation in total debt category among its peers.
NewGenIvf Fundamentals
| Current Valuation | 7.37 M | ||||
| Number Of Shares Shorted | 3.78 K | ||||
| Price To Book | 7.91 X | ||||
| Price To Sales | 1.38 X | ||||
| Revenue | 5.14 M | ||||
| EBITDA | (2.52 M) | ||||
| Net Income | (690.85 K) | ||||
| Total Debt | 1.62 M | ||||
| Cash Flow From Operations | (857.36 K) | ||||
| Market Capitalization | 7.09 M | ||||
| Total Asset | 21.32 M | ||||
| Retained Earnings | (5.67 M) | ||||
| Working Capital | 79 K | ||||
| Net Asset | 21.32 M |
About NewGenIvf Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NewGenIvf Group Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NewGenIvf Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NewGenIvf Group Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether NewGenIvf Group is a strong investment it is important to analyze NewGenIvf Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NewGenIvf Group's future performance. For an informed investment choice regarding NewGenIvf Stock, refer to the following important reports:Check out NewGenIvf Group Piotroski F Score and NewGenIvf Group Altman Z Score analysis. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewGenIvf Group. If investors know NewGenIvf will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NewGenIvf Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NewGenIvf Group is measured differently than its book value, which is the value of NewGenIvf that is recorded on the company's balance sheet. Investors also form their own opinion of NewGenIvf Group's value that differs from its market value or its book value, called intrinsic value, which is NewGenIvf Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NewGenIvf Group's market value can be influenced by many factors that don't directly affect NewGenIvf Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NewGenIvf Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if NewGenIvf Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NewGenIvf Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.